Chengdu Olymvax Biopharmaceuticals (688319.SHG) Q4 2021 Earnings

22FebExpected
Q2 2021
Q3 2021
Q4 2021
0.05
0.07
0.09
0.11

Details

Expected EPS
N/A
Actual EPS
0.08
Surprise EPS
0.08
Surprise Percent
+∞%

Description

Chengdu Olymvax Biopharmaceuticals (688319.SHG) has reported earnings of 0.08 per share for Q4 2021.

0 Comments

Share your thoughts